Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging. (NCT06626022)
A Phase 3, Multicenter, International, Non-inferiority, Randomized Clinical Trial Comparing Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging (MUSIC-Screen)
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to compare whether the FDA and Health Canada approved microUS is as effective as the currently used option (MRI) for imaging the prostate gland. Participants will be randomized into two groups to compare the imaging results of the current standard of care MRI and the new microUS. The study is looking to identify the most effective imaging modality to help guide whether you progress to have a prostate biopsy.
Who can join: Review the eligibility criteria below.
Location: University of California, Los Angeles (UCLA) — Los Angeles, California
Age range: 50 Years to 70 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (9 Sites)
- University of California, Los Angeles (UCLA) — Los Angeles, California
- UT Southwestern Medical Center — Dallas, Texas
- University of Alberta — Edmonton, Alberta
- University of British Columbia — Vancouver, British Columbia
- Sunnybrook Health Sciences Centre — Toronto, Ontario
- CIUSSS du Nord-de-l'Île-de-Montréal — Montréal, Quebec
- CH de Martigues — Martigues,
- Vestfold Hospital Trust — Tønsberg,
- Urologia Clinica Bilbao — Bilbao,
📞 Contact the Study Coordinator
Phone: (780) 407-5800
Email: sbroomfi@ualberta.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Prostate Cancer Screening
- MRI Screening in Men at High Risk of Developing Prostate Cancer — Chicago, Illinois
Explore by condition: All Prostate Cancer Screening clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.